1. WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial;Glover;J Clin Oncol,1986
2. WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma;Glover;J Clin Oncol,1987
3. Cisplatin neuropathy: risk factors, prognosis, and protection by WR-2721;Mollman;Cancer,1988
4. A randomized trial of cyclophosphamide and cisplatin +/− WR-2721 in the treatment of advanced epithelial ovarian cancer;Glick;Proc Am Soc Clin Oncol,1992
5. Phase II study of WR-2721/cisplatin/vinblastine, followed by thoracic radiation (TRT) and WR-2721, in Stage III non-small cell lung cancer (NSCLC);Mehta;Proc Am Soc Clin Oncol,1993